<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/atom10full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><feed xmlns="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/" xmlns:gr="http://www.google.com/schemas/reader/atom/" xmlns:idx="urn:atom-extension:indexing" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" idx:index="no" gr:dir="ltr"><!--
Content-type: Preventing XSRF in IE.

--><generator uri="http://www.google.com/reader">Google Reader</generator><id>tag:google.com,2005:reader/user/02124217703813211020/label/Neuroscience</id><title type="text">Neuroscience News from Elsevier</title><gr:continuation>CJLjn9vphK8C</gr:continuation><author><name>ST</name></author><updated>2012-05-15T10:12:09Z</updated><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/atom+xml" href="http://feeds.feedburner.com/NeuroscienceNews" /><feedburner:info uri="neurosciencenews" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><entry gr:crawl-timestamp-msec="1337076729313"><id gr:original-id="New open access journal – NeuroImage: Clinical  | http://www.journals.elsevier.com/neuroimage-clinical">tag:google.com,2005:reader/item/87bee07a065f6378</id><title type="html">New open access journal – NeuroImage: Clinical</title><published>2012-05-15T00:00:00Z</published><updated>2012-05-15T00:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/hMKrbxnZwK4/neuroimage-clinical" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Announcing a new online only, author-pays, open access journal, NeuroImage: Clinical. Providing a high quality outlet for communicating important advances in the study of abnormal structure-function relationships of the human nervous system based on imaging. Introductory open access publication fee - $1,500. Choose NeuroImage: Clinical for your next open access paper.&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/hMKrbxnZwK4" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://www.journals.elsevier.com/neuroimage-clinical</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1337076729313"><id gr:original-id="Cognitive Enhancers: 22nd Neuropharmacology Conference - Abstract deadline extended to 31 May 2012 | http://www.neuropharmacology-conference.elsevier.com/">tag:google.com,2005:reader/item/73ec4763ece5e01d</id><title type="html">Cognitive Enhancers: 22nd Neuropharmacology Conference - Abstract deadline extended to 31 May 2012</title><published>2012-05-15T00:00:00Z</published><updated>2012-05-15T00:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/O08eAt9VBV0/" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Annual 22nd Neuropharmacology Conference, taking place in New Orleans, USA on 11-12 October 2011. Visit the conference website and submit your abstract on cognitive enhancers by 31 May 2012.
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/O08eAt9VBV0" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://www.neuropharmacology-conference.elsevier.com/</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1337076729313"><id gr:original-id="Suzanne BeDell, Managing Director of Elsevier, interviewed in Research Information | http://content.yudu.com/A1w5il/RIAPRMAY12/resources/16.htm">tag:google.com,2005:reader/item/da50d177f838a815</id><title type="html">Suzanne BeDell, Managing Director of Elsevier, interviewed in Research Information</title><published>2012-05-04T00:00:00Z</published><updated>2012-05-04T00:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/RUfJigWcqCI/16.htm" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Suzanne BeDell was interviewed by Research Information, talking about Elsevier’s eBooks, Print on Demand and apps offering including the Oishi MRI Atlas. &lt;/p&gt;&lt;a href="http://content.yudu.com/A1w5il/RIAPRMAY12/resources/16.htm"&gt;&lt;img src="http://www.elsstjnls.com/feedbuilder2/uploads/133604071156445000.jpg" align="left" border="0"&gt;&lt;/a&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/RUfJigWcqCI" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://content.yudu.com/A1w5il/RIAPRMAY12/resources/16.htm</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1337076729312"><id gr:original-id="7th Brain Research Conference: Abstract deadline extended to 31 May 2012 | http://www.brainresearchconference.com/index.html">tag:google.com,2005:reader/item/d667d1c3c803f923</id><title type="html">7th Brain Research Conference: Abstract deadline extended to 31 May 2012</title><published>2012-05-03T00:00:00Z</published><updated>2012-05-03T00:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/FiqN4wNcSyY/index.html" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Annual 7th Brain Research Conference, taking place in New Orleans, USA on 11-12 October 2011. Visit the conference website and submit your abstract on Optogenetics and Pharmacogenetics by 31 May 2012.&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/FiqN4wNcSyY" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://www.brainresearchconference.com/index.html</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1335977578877"><id gr:original-id="International Conference on Juvenile Myoclonic Epilepsy | http://www.juvenile-myoclonic-epilepsy.com/">tag:google.com,2005:reader/item/0672976c8b1fc5f7</id><title type="html">International Conference on Juvenile Myoclonic Epilepsy</title><published>2012-05-02T00:00:00Z</published><updated>2012-05-02T00:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/9f7bNIRxq3I/" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Patients with JME – or Janz Syndrome – still face suboptimal management due to uncertainty about the criteria, treatment in the different age groups, and lifestyle recommendations worldwide recognition of Juvenile myoclonic epilepsy (JME). However, in the past five years many studies in JME patients have provided crucial new insights. Discover what these will mean for the future of JME, at the International Conference on Juvenile Myoclonic Epilepsy at the Bel Air Hotel, The Hague, The Netherlands on October 26th – 28th 2012. 
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/9f7bNIRxq3I" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://www.juvenile-myoclonic-epilepsy.com/</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1335977578877"><id gr:original-id="BBC Press Coverage Received for Elsevier Organized Conference - Planet Under Pressure | http://www.bbc.co.uk/news/science-environment-17513660">tag:google.com,2005:reader/item/a02a3f26bf1234f4</id><title type="html">BBC Press Coverage Received for Elsevier Organized Conference - Planet Under Pressure</title><published>2012-04-30T00:00:00Z</published><updated>2012-04-30T00:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/22HaChUAPzY/science-environment-17513660" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Planet Under Pressure, organized by Elsevier, reaches beyond the science community to media and blogosphere. Watch the presentations from the conference online today: http://view6.workcast.net/?pak=8051301437434580&amp;amp;cpak=5876441157257134&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/22HaChUAPzY" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://www.bbc.co.uk/news/science-environment-17513660</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1335977578876"><id gr:original-id="Submit your abstract on Cognitive Enhancers | http://bit.ly/iBv3DJ">tag:google.com,2005:reader/item/f8f320b7e3d5ca7e</id><title type="html">Submit your abstract on Cognitive Enhancers</title><published>2012-04-24T00:00:00Z</published><updated>2012-04-24T00:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/cjIPLMNiuMg/iBv3DJ" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Annual 22nd Neuropharmacology Conference, taking place in New Orleans, USA on 11-12 October 2011. Visit the conference website and submit your abstract on Cognitive Enhancers by 14 May 2012.&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/cjIPLMNiuMg" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://bit.ly/iBv3DJ</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1335977578876"><id gr:original-id="Get on top of your game with Elsevier BiggerBrains | http://bit.ly/zII9xw">tag:google.com,2005:reader/item/e74477db0a1bd8e4</id><title type="html">Get on top of your game with Elsevier BiggerBrains</title><published>2012-04-09T00:00:00Z</published><updated>2012-04-09T00:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/YESuzWsSfIw/zII9xw" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Play the BIGGERBRAINS game and power up your research!&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/YESuzWsSfIw" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://bit.ly/zII9xw</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1335977578876"><id gr:original-id="BIGGERBRAINS on Career Planning | http://bit.ly/wQ3wbq">tag:google.com,2005:reader/item/8c9531714d9095c0</id><title type="html">BIGGERBRAINS on Career Planning</title><published>2012-04-02T00:00:00Z</published><updated>2012-04-02T00:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/bGNLXmsliTE/wQ3wbq" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Watch the video interview with the author of Charting a Course for a Successful Research Career, Professor Alan M Johnson, Research Management Services International.&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/bGNLXmsliTE" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://bit.ly/wQ3wbq</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1335977578876"><id gr:original-id="BIGGERBRAINS: A Perspective on Funding in Academic Research | http://bit.ly/wQ3wbq">tag:google.com,2005:reader/item/45793f8c9176fb7f</id><title type="html">BIGGERBRAINS: A Perspective on Funding in Academic Research</title><published>2012-03-30T00:00:00Z</published><updated>2012-03-30T00:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/bGNLXmsliTE/wQ3wbq" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Interview with Prof Francesco Visioli. Chief Scientist at the Madrid Institute for Advanced Studies (IMDEA)-Food, and Editor-in-Chief of Pharmacological Research, giving advice to young scientists about different aspects of funding.&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/bGNLXmsliTE" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://bit.ly/wQ3wbq</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1335199916459"><id gr:original-id="Free Podcast on Optogenetics and Pharmacogenetics in Neuronal Function and Dysfunction | http://www.brainresearchconference.com/podcast.html">tag:google.com,2005:reader/item/ff0941fbb658fb6a</id><title type="html">Free Podcast on Optogenetics and Pharmacogenetics in Neuronal Function and Dysfunction</title><published>2012-03-29T12:00:00Z</published><updated>2012-03-29T12:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/bo8_DzJMi0w/podcast.html" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Listen to this free podcast featuring speakers Karl Deisseroth, Stanford University, USA and Bryan Roth, University of North Carolina, USA about the new fields of Optogenetics and Pharmacogenetics which will be areas of discussion / presentation at this year's Brain Research Conference. The podcast is moderated by Gary Aston-Jones, Medical University of South Carolina, USA.&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/bo8_DzJMi0w" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://www.brainresearchconference.com/podcast.html</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1334844586010"><id gr:original-id="Win an iPad with Elsevier Mobile Application Competition | http://elsevierauthormobileapp.com/">tag:google.com,2005:reader/item/dc9075a80b7c9188</id><title type="html">Win an iPad with Elsevier Mobile Application Competition</title><published>2012-04-19T00:00:00Z</published><updated>2012-04-19T00:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/8I4eoTx-56A/" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Could your idea help authors to submit their papers while they are on the move? Or perhaps you have an idea for an application that involves several journals in a subject area? Whatever your journal app ideas, submit your suggestions to Elsevier’s Best Mobile App Competition today! 

You don’t have to be a Techie, you just need to have good ideas! Put your pen to paper (or fingers to keyboard) and write these ideas down. Who knows? You might even win an iPad for your efforts!

Submit your idea before 31 May 2012! http://elsevierauthormobileapp.com/
&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/8I4eoTx-56A" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://elsevierauthormobileapp.com/</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1334659415324"><id gr:original-id="Submit your abstract on Optogenetics and Pharmacogenetics  | http://www.brainresearchconference.com/index.html">tag:google.com,2005:reader/item/d1e408211db1d3ad</id><title type="html">Submit your abstract on Optogenetics and Pharmacogenetics</title><published>2012-04-17T12:00:00Z</published><updated>2012-04-17T12:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/FiqN4wNcSyY/index.html" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Annual 7th Brain Research Conference, taking place in New Orleans, USA on 11-12 October 2011. Visit the conference website and submit your abstract on Optogenetics and Pharmacogenetics by 1 May 2012.&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/FiqN4wNcSyY" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://www.brainresearchconference.com/index.html</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1333030436768"><id gr:original-id="Free Podcast on Optogenetics and Pharmacogenetics in Neuronal Function and Dysfunction | http://www.brainresearchconference.com/podcast.html">tag:google.com,2005:reader/item/6e801c147ac014f4</id><title type="html">Free Podcast on Optogenetics and Pharmacogenetics in Neuronal Function and Dysfunction</title><published>2012-03-29T00:00:00Z</published><updated>2012-03-29T00:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/bo8_DzJMi0w/podcast.html" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Listen to this free podcast featuring speakers Karl Deisseroth, Stanford University, USA and Bryan Roth, University of North Carolina, USA about the new fields of Optogenetics and Pharmacogenetics which will be areas of discussion / presentation at this year's Brain Research Conference. The podcast is moderated by Gary Aston-Jones, Medical University of South Carolina, USA.&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/bo8_DzJMi0w" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://www.brainresearchconference.com/podcast.html</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1333030436767"><id gr:original-id="BIGGERBRAINS on Networking in your Research Career | http://bit.ly/Alk6tG">tag:google.com,2005:reader/item/4798ae5f0db29ffb</id><title type="html">BIGGERBRAINS on Networking in your Research Career</title><published>2012-03-27T00:00:00Z</published><updated>2012-03-27T00:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/oWqVcod-1oM/Alk6tG" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Interview with Prof Aldo Boccaccini. Department of Materials Science and Engineering University of Erlangen-Nuremberg, Germany, and Editor-in-Chief of Materials Letters. Interview focuses on the importance of networking in the early stages of your career.&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/oWqVcod-1oM" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://bit.ly/Alk6tG</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1333030436767"><id gr:original-id="Brain stimulation enables the solution of an inherently difficult problem | http://bit.ly/H5bM3h">tag:google.com,2005:reader/item/a5b456f7ec3e19d1</id><title type="html">Brain stimulation enables the solution of an inherently difficult problem</title><published>2012-03-26T00:00:00Z</published><updated>2012-03-26T00:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/PiPn6gd4phY/H5bM3h" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Read full article published in Neuroscience Letters. Available online 13 March 2012. &lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/PiPn6gd4phY" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://bit.ly/H5bM3h</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1332850849358"><id gr:original-id="Brain stimulation enables the solution of an inherently difficult problem | http://bit.ly/H5bM3h">tag:google.com,2005:reader/item/62e22b94d227c3cf</id><title type="html">Brain stimulation enables the solution of an inherently difficult problem</title><published>2012-03-26T12:00:00Z</published><updated>2012-03-26T12:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/PiPn6gd4phY/H5bM3h" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Read full article published in Neuroscience Letters. Available online 13 March 2012. &lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/PiPn6gd4phY" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://bit.ly/H5bM3h</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1332850849358"><id gr:original-id="Brain stimulation enables the solution of an inherently difficult problem | http://bit.ly/H5bM3h">tag:google.com,2005:reader/item/62e22b94d227c3cf</id><title type="html">Brain stimulation enables the solution of an inherently difficult problem</title><published>2012-03-26T12:00:00Z</published><updated>2012-03-26T12:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/PiPn6gd4phY/H5bM3h" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Read full article published in Neuroscience Letters. Available online 13 March 2012. &lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/PiPn6gd4phY" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://bit.ly/H5bM3h</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1332773908902"><id gr:original-id="Epilepsy &amp; Behavior has goes purple in support of Purple Day | http://www.journals.elsevier.com/epilepsy-and-behavior/journal-news/epilepsy-behavior-goes-purple-in-support-of-purple-day/">tag:google.com,2005:reader/item/f4fa16008229dd0e</id><title type="html">Epilepsy &amp;amp; Behavior has goes purple in support of Purple Day</title><published>2012-03-26T00:00:00Z</published><updated>2012-03-26T00:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/by2j-qrHfhU/" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;The March issue of Epilepsy &amp;amp; Behavior has gone purple in support of Purple Day (Monday March 26th 2012), celebrated on every continent promoting awareness fo epilepsy&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/by2j-qrHfhU" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://www.journals.elsevier.com/epilepsy-and-behavior/journal-news/epilepsy-behavior-goes-purple-in-support-of-purple-day/</feedburner:origLink></entry><entry gr:crawl-timestamp-msec="1332773908902"><id gr:original-id="BIGGERBRAINS: Publishing and Career Advice to Young, Ambitious Scientists | http://bit.ly/yTBOLj">tag:google.com,2005:reader/item/ff16808306bcb9e7</id><title type="html">BIGGERBRAINS: Publishing and Career Advice to Young, Ambitious Scientists</title><published>2012-03-23T00:00:00Z</published><updated>2012-03-23T00:00:00Z</updated><link rel="alternate" href="http://feedproxy.google.com/~r/NeuroscienceNews/~3/9QDZk8uAnjQ/yTBOLj" type="text/html" /><summary xml:base="http://www.elsevier.com/neuroscience" type="html">&lt;p&gt;Video interview with Dr. Guido Kroemer. Professor at the Faculty of Medicine of the University of Paris Descartes, and Editor-in-Chief of Biochemical and Biophysical Research Communications journal (BBRC).&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/NeuroscienceNews/~4/9QDZk8uAnjQ" height="1" width="1"/&gt;</summary><author gr:unknown-author="true"><name>(author unknown)</name></author><source gr:stream-id="feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml"><id>tag:google.com,2005:reader/feed/http://www.elsstjnls.com/feedbuilder2/feeds/Neuroscience_News.xml</id><title type="html">Neuroscience News</title><link rel="alternate" href="http://www.elsevier.com/neuroscience" type="text/html" /></source><feedburner:origLink>http://bit.ly/yTBOLj</feedburner:origLink></entry></feed>

